Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ines

Ines Atmosukarto, Acton AU

Patent application numberDescriptionPublished
20110212168COMPOSITION FOR TARGETING DENDRITIC CELLS - The present disclosure relates to a composition for targeting dendritic cells. In particular, the present disclosure relates to a composition comprising: a) one or more antigens; b) an anti-DC-SIGN immunoglobulin single variable domain; and c) a carrier which carries a) and b). The disclosure further relates to formulations, compositions and devices comprising such anti-DC-SIGN molecules and their use as a medicament and in the treatment of cancer, suitably melanoma.09-01-2011

Ines Batinic-Haberle, Durham, NC US

Patent application numberDescriptionPublished
20080207582Substituted Porphyrins - A series of ortho isomers of meso tetrakis N-alkylpyridylporphyrins (alkyl being methyl, ethyl, n-propyl, n-butyl, n-hexyl, and n-octyl) and their Mn(III) complexes were synthesized and characterized by elemental analysis, uv/vis spectroscopy, electrospray ionization mass spectrometry and electrochemistry. An increase in the number of carbon atoms in the alkyl chains from 1 to 8 is accompanied by an increase in: (a) lipophilicity measured by the chromatographic retention factor, R08-28-2008
20090318388METHOD OF ACTIVATION OF OXAZAPHOSPHORINES - The present invention provides a method of hydroxylating or oxidizing a compound of interest in a subject (e.g., a cytotoxic oxazaphosphorine prodrug), by administering the compound of interest to the subject; and concurrently administering the subject a metalloporphyrin in an amount effective to hydroxylate or oxidize the compound of interest in the subject.12-24-2009
20100305083SUBSTITUTED PORPHYRINS - To improve bioavailability of the catalytic metalloporphyrin-based SOD mimics Mn(III) 5,10,15,20-tetrakis[N-ethylpyridinium-2-yl]porphyrin (MnTE-2-PyP12-02-2010
20110065679Substituted Porphyrins - The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.03-17-2011
20110275606SUBSTITUTED PORPHYRINS - Discloses are compounds according to Formula I. Further provided are methods of reducing oxidative stress in a cell, methods of treating a disease including cancer, and methods of treating a subject with a disorder associated with oxidative stress, the methods including administering a compound according to the invention. Also disclosed are methods of potentiating a cancer cell for treatment with ionizing radiation or chemotherapeutics including contacting the cell with an effective amount of a compound according to the invention. Further discloses are pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a compound according to the invention.11-10-2011

Patent applications by Ines Batinic-Haberle, Durham, NC US

Ines Becker, Nurnberg DE

Patent application numberDescriptionPublished
20110244354Fuel Cell System and Method for Production Thereof - A contact used to electrically connect High-temperature density fuel cells together is provided. The contact includes at least one hollow cord which each has at least three contact surfaces with the fuel cell, of which two contact surfaces connect neighboring anode surfaces and the third contact surface connects the interconnector of the next High-temperature density fuel cell. A method for producing a fuel cells system including high-power density fuel cells is also provided.10-06-2011
20110262841Aid for Electrical Contacting of High-Temperature Fuel Cells and Method for Production Thereof - A double-sided adhesive metal-based tape for use as contacting aid for SOFC fuel cells is provided. The double-sided metal-based adhesive tape is suitable for simplifying the construction of cell bundles. The double-sided metal-based adhesive tape is used for electrical contacting of the cell connector with the anode and for electrical contacting of the interconnector of the fuel cells with the cell connector. A method for producing the double-sided adhesive metal-base tape is also provided.10-27-2011

Ines Carranco Moruno, Sta. Coloma De Cervello ES

Patent application numberDescriptionPublished
201001057235-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS - The present disclosure relates to compounds of formula (I):04-29-2010

Ines De Lannoy, Toronto CA

Patent application numberDescriptionPublished
20100304984PREDICTION OF POTENTIAL DRUG-DRUG INTERACTIONS USING GENE EXPRESSION PROFILING OF DRUG TRANSPORTERS, CYTOCHROME P450S AND NUCLEAR X RECEPTORS - The invention provides materials and methods for detecting the expression of genes encoding cytochrome p450, nuclear X receptors, phase H transferases, and solute carrier family uptake pumps. The materials include sets of primers, PCR amplicons and arrays. The methods of the invention include hybridization assays. Kits and assays for the detection of the expression of the genes are also provided by the invention. In addition, the invention provides the use of the materials and methods of the invention in drug screening assays.12-02-2010

Ines Eulitz, Freiberg DE

Patent application numberDescriptionPublished
20090050242METHOD OF FABRICATING STRIPS OR FOILS, RESPECTIVELY, FROM TiA16V4 - A method of fabricating a superplastically formable strip or a superplastically formable foil from TiAl6V4 with a thickness of no more than 0.9 mm, preferably less than or equal to 0.5 mm, comprises the steps: 02-26-2009

Ines Ibanez-Tallon, New York, NY US

Patent application numberDescriptionPublished
20100004162Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof - The present invention provides a novel family of polypeptides which are ligand-gated channel receptor accessory molecules or ligands, denoted Lynx. This invention provides an isolated polypeptide comprising an amino acid sequence of a Lynx polypeptide in which the amino acid sequence is set forth in SEQ ID NO:2, SEQ ID NO:4 or SEQ ID NO:15, including fragments, mutants, variants, analogs, homologs, or derivatives, thereof. This invention further provides an isolated immunogenic polypeptide comprising an amino acid sequence of a Lynx polypeptide and relates to antibodies of Lynx polypeptides and the use of such antibodies. The invention provides an isolated nucleic acid encoding a polypeptide comprising an amino acid sequence of a Lynx polypeptide. This invention provides pharmaceutical compositions and diagnostic and therapeutic methods of use of the isolated polypeptides and nucleic acids of the present invention. Assays for compounds which mimic, alter or inactivate the polypeptides of the present invention for use in therapy are also provided. The present invention further relates to methods of isolating Lynx polypeptides and the nucleic acids encoding such polypeptides.01-07-2010

Ines Lopez Arteaga, Eindhoven NL

Patent application numberDescriptionPublished
20110120222ACOUSTIC HOLOGRAPHY - A method of performing near- field acoustic holography comprises the following steps. Establishing (05-26-2011

Ines Mingozzi, Ferrara IT

Patent application numberDescriptionPublished
20120041161Process for the Preparation of Polymer of 1-Butene - A process for the preparation of 1-butene homopolymers or 1-butene/alpha olefin copolymers wherein the alpha olefins are selected from ethylene, propylene or alpha olefms of formula CH02-16-2012

Ines Muller, Heidelberg DE

Patent application numberDescriptionPublished
20090203061DEVICE AND METHOD FOR OBSERVING THE ORGANIZATION OF STUDIED CELLS CULTURED IN THE PRESENCE OF A CONCENTRATION GRADIENT OF CHEMOTACTIC MOLECULES - The device comprises a cell culture compartment (08-13-2009

Ines Petschen, Barcelona ES

Patent application numberDescriptionPublished
20090005566Method for Making 1-Substituted 1H-Imidazo [4,5-C] Quinolin-4-Amine Compounds and Intermediates Therefor - The present invention concerns a method for manufacturing 1-substituted 1H imidazo[4,5-c]quinolin-4-amine compounds through their corresponding formamides. The invention also concerns new formamide intermediates.01-01-2009
20090005573Method for Manufacturing Imidazole Compounds and Salts and Pseudopolymorphs Thereof - The invention relates to a method for manufacturing sertaconazole mononitrate. The invention also relates tcserta-conazole mononitrate that is characterized by it: particle size and to sertaconazole mononitrate monohydrate.01-01-2009

Patent applications by Ines Petschen, Barcelona ES

Ines Poggensee, Heilshoop DE

Patent application numberDescriptionPublished
20090149927METHOD AND APPARATUS FOR CONTROLLING A WARMING THERAPY DEVICE - An apparatus and method for controlling a warming therapy device (e.g., incubator, warmer, etc.) is described. In one exemplary embodiment, the apparatus includes a Graphical User Interlace (GUI) coupled to the warming therapy device for monitoring patient medical information, and for controlling various aspects of the warming therapy device accordingly.06-11-2009

Ines Prautzsch, Tabarz DE

Patent application numberDescriptionPublished
20090238655WORKPIECE TABLE ARRANGEMENT - A workpiece table arrangement for a milling and drilling machine comprising a rigid machine tool frame comprising an upper cross girth, a machining unit movable on the front side of the cross girth along at least two coordinate axes by means of a motor and including a rotationally driven work spindle including exchangeable tools. The workpiece table is disposed in front of the machine tool frame and horizontally movable along at least one coordinate axis by means of a motor and comprises a tabletop for clamping at least one workpiece. The machine tool frame comprises two rigid side walls rigidly connected to each other by the upper crossbar and a front end.09-24-2009

Patent applications by Ines Prautzsch, Tabarz DE

Ines Swobda, Klagenfurt AT

Patent application numberDescriptionPublished
20100303843RECOMBINANT ALLERGEN WITH REDUCED lgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY - The present invention relates generally to reagents useful in the immunotherapeutic or immunoprophylactic treatment of allergic diseases. More particularly, the present invention provides modified allergens exhibiting reduced IgE interactivity including reduced IgE production-stimulatory activity, while retaining T-cell antigenicity, which are useful in the immunomodulation of type I allergic disease conditions. The present invention further contemplates a method of immunomodulation of allergic diseases such as type I allergic disease conditions by the administration of modified allergens exhibiting reduced IgE interactivity while retaining T-cell antigenicity.12-02-2010

Ines Unterwurzacher, Innsbruck AT

Patent application numberDescriptionPublished
20100233746Inflammation and Oxidative Stress Level Assay - The present invention relates to a method for determining the systemic metabolic status of an organism in relation to inflammation and oxidative stress using a biological sample (Inflammation and Oxidative Stress Level Assay). This comprises detection and quantification of one or more derivatives of arachidonic acid (eicosanoids), linoleic acid and/or docosahexaenoic acid, preferably together with one or more oxidative stress parameters and/or with one or more analytes from other metabolite classes in parallel, as well as a kit adapted for carrying out such a method. Moreover, the invention relates to the biomarkers as employed in the method.09-16-2010

Ines Vincuenia, Madrid ES

Patent application numberDescriptionPublished
20080216893Process for Manufacturing Photovoltaic Cells - A process for making a photovoltaic cell comprising forming a first layer on a front surface of a semiconductor wafer, the wafer comprising a first dopant and the first layer comprising a dopant of a conductivity type opposite the first dopant; depositing a surface coating on the front surface over the first layer; forming grooves in the front surface after depositing the surface coating thereon; doping the grooves with a dopant having a conductivity opposite the first dopant; treating a back surface of the wafer to remove at least substantially all dopant having a conductivity type opposite the first dopant; forming a back surface field; forming a back electrical contact over the back surface; and adding an electrically conductive material to the grooves to form a front electrical contact.09-11-2008

Ines Vincueria, Madrid ES

Patent application numberDescriptionPublished
20100193016Photovoltaic Cell and Production Thereof - A process for producing a photovoltaic device having a substrate comprising silicon doped with a first dopant, the process comprising the steps of: a. forming a first layer over a front surface of the substrate, the first layer comprising a second dopant of a conductivity type opposite the first dopant; b. forming a second surface coating over the first layer; c. forming elongate grooves reaching or entering the silicon substrate, d. forming a third layer within the grooves, the layer comprising a third dopant of a conductivity type opposite to the first dopant; e. forming a contact finger system which intersects with the grooves to provide an electrically conducting front contact; and f. forming a second contact.08-05-2010